Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP611553.RAoIMoP0opzzJK2a3rpJ6G-wn3LDP32UX0xJP0_5EMT-g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP611553.RAoIMoP0opzzJK2a3rpJ6G-wn3LDP32UX0xJP0_5EMT-g130_assertion type Assertion NP611553.RAoIMoP0opzzJK2a3rpJ6G-wn3LDP32UX0xJP0_5EMT-g130_head.
- NP611553.RAoIMoP0opzzJK2a3rpJ6G-wn3LDP32UX0xJP0_5EMT-g130_assertion description "[We have employed chimeric antisense oligonucleotides to investigate the molecular alterations after targeted interference with Plk1 in RKO human colon adenocarcinoma and PC3 prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP611553.RAoIMoP0opzzJK2a3rpJ6G-wn3LDP32UX0xJP0_5EMT-g130_provenance.
- NP611553.RAoIMoP0opzzJK2a3rpJ6G-wn3LDP32UX0xJP0_5EMT-g130_assertion evidence source_evidence_literature NP611553.RAoIMoP0opzzJK2a3rpJ6G-wn3LDP32UX0xJP0_5EMT-g130_provenance.
- NP611553.RAoIMoP0opzzJK2a3rpJ6G-wn3LDP32UX0xJP0_5EMT-g130_assertion SIO_000772 16648550 NP611553.RAoIMoP0opzzJK2a3rpJ6G-wn3LDP32UX0xJP0_5EMT-g130_provenance.
- NP611553.RAoIMoP0opzzJK2a3rpJ6G-wn3LDP32UX0xJP0_5EMT-g130_assertion wasDerivedFrom befree-20140225 NP611553.RAoIMoP0opzzJK2a3rpJ6G-wn3LDP32UX0xJP0_5EMT-g130_provenance.
- NP611553.RAoIMoP0opzzJK2a3rpJ6G-wn3LDP32UX0xJP0_5EMT-g130_assertion wasGeneratedBy ECO_0000203 NP611553.RAoIMoP0opzzJK2a3rpJ6G-wn3LDP32UX0xJP0_5EMT-g130_provenance.